Diagnosing pancreatic tumors using contrast-enhanced harmonic endoscopic ultrasonography with Sonazoid

Naoki Yamamoto, Hironari Katou, Sho Mizukawa, Shinichiro Muro, Yutaka Akimoto, Daisuke Uchida, Takeshi Tomoda, Kazuyuki Matsumoto, Shigeru Horiguchi, Koichiro Tsutsumi, Hiroyuki Okada

Research output: Contribution to journalArticle

Abstract

Contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) with contrast agent enabled us to assess the hemodynamics closely, despite limited data in pancreatic tumors. We have initiated a prospective, single arm, and non-randomized study to clarify the accuracy and safety of CH-EUS with Sonazoid and time-intensity curve (TIC) analysis for diagnosing benign or malignant pancreatic tumors. A total of 200 patients will undergo CH-EUS and TIC analysis. Receiver operating characteristic (ROC) analysis will be used to determine the optimal parameter cutoff values for TIC analysis. This will clarify whether CH-EUS and TIC can further improve the diagnosis of pancreatic tumors over conventional EUS.

Original languageEnglish
Pages (from-to)323-326
Number of pages4
JournalActa Medica Okayama
Volume70
Issue number4
Publication statusPublished - 2016

Fingerprint

Ultrasonography
Endosonography
Tumors
Neoplasms
Hemodynamics
ROC Curve
Contrast Media
Safety
Sonazoid

Keywords

  • CH-EUS
  • Pancreatic tumor
  • TIC

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{b683f73c699747b0bc121a3288355e09,
title = "Diagnosing pancreatic tumors using contrast-enhanced harmonic endoscopic ultrasonography with Sonazoid",
abstract = "Contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) with contrast agent enabled us to assess the hemodynamics closely, despite limited data in pancreatic tumors. We have initiated a prospective, single arm, and non-randomized study to clarify the accuracy and safety of CH-EUS with Sonazoid and time-intensity curve (TIC) analysis for diagnosing benign or malignant pancreatic tumors. A total of 200 patients will undergo CH-EUS and TIC analysis. Receiver operating characteristic (ROC) analysis will be used to determine the optimal parameter cutoff values for TIC analysis. This will clarify whether CH-EUS and TIC can further improve the diagnosis of pancreatic tumors over conventional EUS.",
keywords = "CH-EUS, Pancreatic tumor, TIC",
author = "Naoki Yamamoto and Hironari Katou and Sho Mizukawa and Shinichiro Muro and Yutaka Akimoto and Daisuke Uchida and Takeshi Tomoda and Kazuyuki Matsumoto and Shigeru Horiguchi and Koichiro Tsutsumi and Hiroyuki Okada",
year = "2016",
language = "English",
volume = "70",
pages = "323--326",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "4",

}

TY - JOUR

T1 - Diagnosing pancreatic tumors using contrast-enhanced harmonic endoscopic ultrasonography with Sonazoid

AU - Yamamoto, Naoki

AU - Katou, Hironari

AU - Mizukawa, Sho

AU - Muro, Shinichiro

AU - Akimoto, Yutaka

AU - Uchida, Daisuke

AU - Tomoda, Takeshi

AU - Matsumoto, Kazuyuki

AU - Horiguchi, Shigeru

AU - Tsutsumi, Koichiro

AU - Okada, Hiroyuki

PY - 2016

Y1 - 2016

N2 - Contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) with contrast agent enabled us to assess the hemodynamics closely, despite limited data in pancreatic tumors. We have initiated a prospective, single arm, and non-randomized study to clarify the accuracy and safety of CH-EUS with Sonazoid and time-intensity curve (TIC) analysis for diagnosing benign or malignant pancreatic tumors. A total of 200 patients will undergo CH-EUS and TIC analysis. Receiver operating characteristic (ROC) analysis will be used to determine the optimal parameter cutoff values for TIC analysis. This will clarify whether CH-EUS and TIC can further improve the diagnosis of pancreatic tumors over conventional EUS.

AB - Contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) with contrast agent enabled us to assess the hemodynamics closely, despite limited data in pancreatic tumors. We have initiated a prospective, single arm, and non-randomized study to clarify the accuracy and safety of CH-EUS with Sonazoid and time-intensity curve (TIC) analysis for diagnosing benign or malignant pancreatic tumors. A total of 200 patients will undergo CH-EUS and TIC analysis. Receiver operating characteristic (ROC) analysis will be used to determine the optimal parameter cutoff values for TIC analysis. This will clarify whether CH-EUS and TIC can further improve the diagnosis of pancreatic tumors over conventional EUS.

KW - CH-EUS

KW - Pancreatic tumor

KW - TIC

UR - http://www.scopus.com/inward/record.url?scp=84984848316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984848316&partnerID=8YFLogxK

M3 - Article

C2 - 27549682

AN - SCOPUS:84984848316

VL - 70

SP - 323

EP - 326

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 4

ER -